A new scoping review, highlighted by EatingWell. from a recent study published in nature , maps evidence across 281 associations between dairy intake and adult health outcomes. The review aggregates findings from studies covering five domains—cardiovascular disease, cancers, body weight, mortality, and other outcomes (incl. type-2 diabetes, bone/joint and cognitive health).
Key takeaways with trade relevance: (1) overall dairy consumption was more often associated with reduced risk of heart disease, several cancers (notably bladder, breast, colorectal), type-2 diabetes and obesity; (2) yogurt and fermented dairy showed the most consistent benefits—25 studies found risk reduction for outcomes such as CVD, T2D and some cancers, with no studies linking yogurt to increased risk; (3) cheese showed several protective signals for CVD and some cancers, though many studies were neutral; (4) across 27 studies comparing fat levels, both full-fat and low-fat dairy were frequently linked to better heart health, with few showing harm; (5) a minority of studies (five) associated dairy with higher risks for specific cancers (e.g., liver, ovarian, prostate), underscoring heterogeneity and the observational nature of the evidence.
For dairy marketers and R&D, the weight of evidence around fermented categories (yogurt, kefir) as well as tolerance for whole-milk formats may support premiumization, reformulation, and claims frameworks—while staying conservative on cancer claims given mixed findings and non-causal design.
Industry Insight:
For Indian players—including Hatsun—this strengthens the case for expanding fermented portfolios (dahi, yogurt drinks, probiotic SKUs) and maintaining whole-milk lines, paired with science-grounded messaging and rigorous compliance review of health claims.
Source : Dairynews7x7 Aug 14th 2025 EatingWell